Kanamycin SulfateBroad spectrum antibiotic CAS# 25389-94-0 |
- 3,3'-Diindolylmethane
Catalog No.:BCC1306
CAS No.:1968-05-4
- BAM7
Catalog No.:BCC1397
CAS No.:331244-89-4
- Bendamustine HCl
Catalog No.:BCC1153
CAS No.:3543-75-7
- Betulinic acid
Catalog No.:BCN5524
CAS No.:472-15-1
- Brassinolide
Catalog No.:BCC1438
CAS No.:72962-43-7
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 25389-94-0 | SDF | Download SDF |
| PubChem ID | 441374 | Appearance | Powder |
| Formula | C18H38N4O15S | M.Wt | 582.58 |
| Type of Compound | N/A | Storage | Desiccate at -20°C |
| Synonyms | Kanamycin A monosulfate | ||
| Solubility | H2O : 100 mg/mL (171.65 mM; Need ultrasonic) DMSO : < 1 mg/mL (insoluble or slightly soluble) | ||
| Chemical Name | (2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol;sulfuric acid | ||
| SMILES | C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O | ||
| Standard InChIKey | OOYGSFOGFJDDHP-KMCOLRRFSA-N | ||
| Standard InChI | InChI=1S/C18H36N4O11.H2O4S/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17;1-5(2,3)4/h4-18,23-29H,1-3,19-22H2;(H2,1,2,3,4)/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-;/m1./s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Broad spectrum antibiotic. |
Kanamycin Sulfate Dilution Calculator
Kanamycin Sulfate Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.7165 mL | 8.5825 mL | 17.165 mL | 34.33 mL | 42.9126 mL |
| 5 mM | 0.3433 mL | 1.7165 mL | 3.433 mL | 6.866 mL | 8.5825 mL |
| 10 mM | 0.1717 mL | 0.8583 mL | 1.7165 mL | 3.433 mL | 4.2913 mL |
| 50 mM | 0.0343 mL | 0.1717 mL | 0.3433 mL | 0.6866 mL | 0.8583 mL |
| 100 mM | 0.0172 mL | 0.0858 mL | 0.1717 mL | 0.3433 mL | 0.4291 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
soluble in water at 50mg/ml recommend our Ultra Pure, Nuclease free water, AB02123 typically used at 100mg/ml for cell culture protect from moisture Store: 2-8°C.
- AR-C 102222
Catalog No.:BCC6092
CAS No.:253771-21-0
- TRIM
Catalog No.:BCC6847
CAS No.:25371-96-4
- Asperulosidic acid
Catalog No.:BCN3088
CAS No.:25368-11-0
- Litseglutine B
Catalog No.:BCN5120
CAS No.:25368-01-8
- 2-Amino-6-methylbenzothiazole
Catalog No.:BCC8543
CAS No.:2536-91-6
- 16-O-Acetylpolyporenic acid C
Catalog No.:BCN4058
CAS No.:2535-06-0
- Wiskostatin
Catalog No.:BCC7934
CAS No.:253449-04-6
- (+)-Corlumidine
Catalog No.:BCN2662
CAS No.:25344-54-1
- Viniferin
Catalog No.:BCN3757
CAS No.:253435-07-3
- Trazodone HCl
Catalog No.:BCC5032
CAS No.:25332-39-2
- BMS 195614
Catalog No.:BCC7740
CAS No.:253310-42-8
- Isocalamendiol
Catalog No.:BCN5119
CAS No.:25330-21-6
- Morroniside
Catalog No.:BCN5009
CAS No.:25406-64-8
- Boc-ß-HoAsp(OBzl)-OH
Catalog No.:BCC3229
CAS No.:254101-10-5
- Phellopterin
Catalog No.:BCN2637
CAS No.:2543-94-4
- H-Cys(pMeOBzl)-OH
Catalog No.:BCC2909
CAS No.:2544-31-2
- Dehydropitavastatin ethyl ester
Catalog No.:BCC8931
CAS No.:254452-91-0
- (+)-Afzelechin
Catalog No.:BCN5121
CAS No.:2545-00-8
- Felbamate
Catalog No.:BCC4904
CAS No.:25451-15-4
- H-D-Glu-OtBu
Catalog No.:BCC2938
CAS No.:25456-76-2
- H-Asn-OtBu
Catalog No.:BCC2877
CAS No.:25456-86-4
- Demethyleneberberine
Catalog No.:BCN2829
CAS No.:25459-91-0
- 2-MPPA
Catalog No.:BCC7995
CAS No.:254737-29-6
- Emricasan
Catalog No.:BCC5367
CAS No.:254750-02-2
[Ototoxicity of kanamycin sulfate in adult rats and its underlying mechanisms].[Pubmed:21505733]
Sheng Li Xue Bao. 2011 Apr 25;63(2):171-6.
The aim of the present study was to assess the ototoxicity of Kanamycin Sulfate (KM) in adult rats and its underlying mechanism. Forty male Sprague-Dawley rats (6-7 weeks old) were randomly divided into the experimental group and the control group. The animals in the experimental group were injected subcutaneously with KM (500 mg/kg per day) for two weeks, and the control group received equal volume of normal saline. To assess the ototoxicity of KM, the auditory brainstem response (ABR) was recorded to monitor the changes in hearing thresholds, and the density of spiral ganglion cells (SGCs) and morphology of cochlea were observed using surface preparations and frozen sections of cochlea. The results showed that the hearing threshold of rats in the experimental group was elevated by more than 60 dB across all the frequencies two weeks after the first administration of KM. And in the experimental group, the density of SGCs became lower, and organ of Corti suffered loss of hair cells. The loss of outer hair cells (OHCs) was more severe than that of inner hair cells (IHCs), correlated with the density decrease of SGCs. We conclude that the ototoxicity of KM in the adult rats was apparent and the underlying mechanism is associated with the loss of SGCs and hair cells.
Development and validation of a simple capillary zone electrophoresis method for the analysis of kanamycin sulfate with UV detection after pre-capillary derivatization.[Pubmed:11521896]
J Chromatogr A. 2001 Jul 27;924(1-2):451-8.
Capillary zone electrophoresis was successfully applied to separate eight related substances of kanamycin and several minor unknowns from the main component. Strategies to enhance derivatization and selectivity and to optimize separation parameters involved the application of experimental designs. This chemometrical approach considers main effects as well as interactions of the influential parameters, thus conducting a more thorough investigation of the method than the common step-by-step approach. Central composite face centered designs established optimal separation conditions: 30 mM borax buffer, pH 10.0 containing 16.0% (v/v) methanol and optimal composition of derivatization reagent: 27 mg/ml 1,2-phthalic dicarboxaldehyde and 25 microl/ml mercaptoacetic acid in borate buffer, pH 10.4. The standard curves were linear over the concentration range of 0.007-1.01 mg/ml for the main component and 0.003-0.1 mg/ml for the related substances. The limit of quantitation was 0.14% (m/m) for the related substances and impurities (S/N= 10). The assay method was used to determine the composition of several commercial samples. Quantitative analysis indicates potential usefulness of capillary electrophoresis as an alternative to the assay method prescribed in the European Pharmacopoeia and the United States Pharmacopeia.
Analysis of kanamycin sulfate by liquid chromatography with pulsed electrochemical detection.[Pubmed:9134733]
J Chromatogr A. 1997 Apr 4;766(1-2):133-9.
The analysis of Kanamycin Sulfate by liquid chromatography using a column packed with poly(styrene-divinylbenzene) and pulsed electrochemical detection on a gold electrode is described. A two-step gradient was necessary to obtain a good separation together with a reasonable analysis time of maximum 45 min. The mobile phases consisted of an aqueous solution of 20 g/l or 60 g/l sodium sulfate, 1.3 g/l sodium octanesulfonate and 50 ml/l 0.2 M phosphate buffer pH 3.0. Sodium hydroxide was added post-column. The influence of the different chromatographic parameters on the separation was investigated. A number of commercial samples were analyzed using this method. Besides the previously reported impurities, such as kanamycins B and C, two other impurities were separated, one of which is called kanamycin D. In total, eight components were separated.
[Research progress of acute kanamycin sulfate-induced deafness in guinea pig].[Pubmed:22870728]
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 May;26(10):478-80.
To present a summary of current knowledge regarding acute Kanamycin Sulfate-induced deafness in guinea pig, by reviewing the published literature. Animal model of acute deafness induced by a single dose of Kanamycin Sulfate in combination with ethacrynic acid or furosemide in guinea pig was usually used to investigate the mechanism of cochlear cell degeneration. There were different time sequences of cell degeneration of spiral ganglion cell and hair cell in different studies. The findings may result from different doses, order of two drugs administration or time point chosen. There remains scope for further research in chronic kanamycin-induced deafness, which more replicates the type of exposure to people than acute deafness.
